129 related articles for article (PubMed ID: 11401315)
1. Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients.
Taylor DD; Bender DP; Gerçel-Taylor C ; Stanson J; Whiteside TL
Br J Cancer; 2001 Jun; 84(12):1624-9. PubMed ID: 11401315
[TBL] [Abstract][Full Text] [Related]
2. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
Taylor DD; Gerçel-Taylor C; Lyons KS; Stanson J; Whiteside TL
Clin Cancer Res; 2003 Nov; 9(14):5113-9. PubMed ID: 14613988
[TBL] [Abstract][Full Text] [Related]
3. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
5. HSP-10 in ovarian cancer: expression and suppression of T-cell signaling.
Akyol S; Gercel-Taylor C; Reynolds LC; Taylor DD
Gynecol Oncol; 2006 Jun; 101(3):481-6. PubMed ID: 16386781
[TBL] [Abstract][Full Text] [Related]
6. Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions.
Alaibac M; Pigozzi B; Saponeri A; Belloni-Fortina A; Peserico A
Arch Dermatol Res; 2002 Nov; 294(8):380-2. PubMed ID: 12420108
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.
Nambiar MP; Enyedy EJ; Fisher CU; Krishnan S; Warke VG; Gilliland WR; Oglesby RJ; Tsokos GC
Arthritis Rheum; 2002 Jan; 46(1):163-74. PubMed ID: 11817588
[TBL] [Abstract][Full Text] [Related]
8. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
9. Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR zeta) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: possible clinical relevance.
Laytragoon-Lewin N; Porwit-MacDonald A; Mellstedt H; Lewin F
Anticancer Res; 2000; 20(2B):1093-100. PubMed ID: 10810402
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients.
Frydecka I; Zimecki M; Bocko D; Kosmaczewska A; Teodorowska R; Ciszak L; Kruzel M; Wlodarska-Polinsk J; Kuliczkowski K; Kornafel J
Anticancer Res; 2002; 22(3):1897-901. PubMed ID: 12168890
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients.
Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
Am J Nephrol; 2008; 28(1):152-7. PubMed ID: 17951997
[TBL] [Abstract][Full Text] [Related]
12. Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients.
Taylor DD; Edwards RP; Case CR; Gerçel-Taylor C
Gynecol Oncol; 2004 Jul; 94(1):54-60. PubMed ID: 15262119
[TBL] [Abstract][Full Text] [Related]
13. Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients.
Schmielau J; Nalesnik MA; Finn OJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):933s-939s. PubMed ID: 11300494
[TBL] [Abstract][Full Text] [Related]
14. Short-term dexamethasone treatment modulates the expression of the murine TCR zeta gene locus.
Ronchetti S; Nocentini G; Giunchi L; Bartoli A; Moraca R; Riccardi C; Migliorati G
Cell Immunol; 1997 Jun; 178(2):124-31. PubMed ID: 9225003
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
Kono K; Ressing ME; Brandt RM; Melief CJ; Potkul RK; Andersson B; Petersson M; Kast WM; Kiessling R
Clin Cancer Res; 1996 Nov; 2(11):1825-8. PubMed ID: 9816136
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.
Takeuchi T; Tsuzaka K; Abe T
Int Rev Immunol; 2004; 23(3-4):273-91. PubMed ID: 15204089
[TBL] [Abstract][Full Text] [Related]
17. The chicken TCR zeta-chain restores the function of a mouse T cell hybridoma.
Göbel TW; Bolliger L
J Immunol; 1998 Feb; 160(4):1552-4. PubMed ID: 9469409
[TBL] [Abstract][Full Text] [Related]
18. L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells.
Taheri F; Ochoa JB; Faghiri Z; Culotta K; Park HJ; Lan MS; Zea AH; Ochoa AC
Clin Cancer Res; 2001 Mar; 7(3 Suppl):958s-965s. PubMed ID: 11300497
[TBL] [Abstract][Full Text] [Related]
19. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules.
Cemerski S; van Meerwijk JP; Romagnoli P
Eur J Immunol; 2003 Aug; 33(8):2178-85. PubMed ID: 12884292
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of the zeta-chain dimerization motif for TCR surface expression.
Bolliger L; Johansson B
J Immunol; 1999 Oct; 163(7):3867-76. PubMed ID: 10490986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
